US Edition
Novelty Nobility joining hands with AGC Biologics
Summary by News Article Insiders
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Novelty Nobility joining hands with AGC Biologics
Shown above is the logo of Novelty Nobility. [Photo courtesy of Novelty Nobility] South Korea’s antibody drug developer Novelty Nobility is advancing its lead bispecific antibody drug candidate toward clinical trials in partnership with AGC Biologics, a global contract development and manufacturing organization (CDMO). On May 6, AGC Biologics announced that it had signed a collaboration agreement with Novelty Nobility to jointly develop a produc…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
